Peptide Schedule
MGF (Mechano Growth Factor)24 residuesYQPPSTNKNTKSQRRKGSTFEERKEach bubble = one amino acid. Size = residue mass. Color = chemical class.MGF (Mechano Growth Factor)
Benefits
About MGF (Mechano Growth Factor)
MGF (Mechano Growth Factor) is the 24-amino-acid C-terminal peptide derived from the IGF-1Ec splice variant. When muscle tissue is stretched, damaged, or subjected to mechanical load, the IGF-1 gene undergoes alternative splicing to produce the Ec isoform — releasing MGF locally at the site of injury. Unlike systemic IGF-1, MGF acts as an immediate-early repair signal: it activates quiescent muscle satellite (stem) cells, pushing them into the cell cycle to begin proliferating without triggering premature differentiation. This distinction is important — satellite cell activation is the rate-limiting step in muscle repair. In preclinical models, MGF expression peaks within 1-6 hours of mechanical stimulus and returns to baseline within 24-72 hours, after which the IGF-1Ea isoform takes over to drive differentiation and protein synthesis. The synthetic MGF peptide replicates this E-domain signal. However, its native half-life is only 5-7 minutes due to rapid enzymatic degradation, making practical dosing difficult. Most research protocols call for localized injection near the trained muscle immediately post-exercise. Beyond skeletal muscle, MGF has shown neuroprotective activity in aging mouse brain tissue and plays a role in cardiac tissue repair after ischemic injury. All current evidence is from cell culture and animal studies — no human clinical trials have been completed.
Who Should Consider MGF (Mechano Growth Factor)
- Athletes and bodybuilders seeking accelerated muscle recovery
- Researchers studying satellite cell biology and muscle regeneration
- Adults with age-related muscle wasting (sarcopenia) — preclinical interest
- Individuals recovering from muscle injuries — preclinical interest
- Cardiac researchers investigating post-ischemic tissue repair
How MGF (Mechano Growth Factor) Works
MGF is produced by alternative splicing of the IGF-1 gene under mechanical stress. The unique Ec E-domain peptide acts independently of the IGF-1 receptor (IGF-1R). Instead, it signals through a distinct pathway to activate muscle satellite cells — the resident stem cells responsible for muscle regeneration. MGF shifts satellite cells from a quiescent G0 state into the cell cycle (G1/S phase), increasing the proliferative pool of myogenic progenitors. This occurs without inducing differentiation, which is later driven by the IGF-1Ea isoform acting through IGF-1R. In cardiac tissue, MGF has been shown to reduce apoptosis and promote progenitor cell migration to ischemic areas. In neural tissue, it promotes neurogenesis by activating neural progenitor cells in the hippocampus.
What to Expect
Initial adaptation period. Injection site soreness is common early on. No measurable muscle changes expected. Users may notice mild post-workout soreness reduction if injection timing is correct.
Anecdotal reports of improved recovery between sessions and reduced delayed-onset muscle soreness (DOMS). No clinical data supports specific timelines. Effects are highly dependent on injection site and timing.
End of typical cycle. Some users report improved training capacity and recovery. Any observed effects are anecdotal — no controlled human trials exist to validate timelines. Begin taper or transition to off-cycle period.
Allow receptor sensitivity to normalize. Maintain training volume. Some users stack with BPC-157 or TB-500 during the off-cycle for continued recovery support.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 200mcg | Daily |
| Aggressive | 300mcg | Daily |
Note: Extremely short half-life — must be injected immediately post-workout for any localized effect. Most users prefer the PEGylated version (PEG-MGF) for practical dosing. Inject near the target muscle site, not systemically. Cycle 4-6 weeks on, 4 weeks off. Store reconstituted vial refrigerated and use within 7-10 days.
How to Inject MGF (Mechano Growth Factor)
Inject intramuscularly near the target muscle within minutes of completing a workout. Use an insulin syringe for accuracy. For localized effect, split the dose bilaterally if training paired muscle groups. Rotate injection sites within the target area. Some protocols use subcutaneous abdominal injection, but localized IM injection is preferred for muscle-specific effects.
Cycling Protocol
Cycle 4-6 weeks on, 4 weeks off. Inject immediately post-workout near the target muscle. Due to the extremely short half-life, timing is critical — delays of even 30 minutes reduce effectiveness.
Pharmacokinetics
Source: Estimated ~5-7 minutes; Goldspink G, Endocrinology 2010 (PMID 20130113)
Loading the interactive decay curve.
Side Effects
Injection site reactions (pain, redness, swelling). Possible water retention and temporary bloating. Hypoglycemia risk at higher doses — monitor blood sugar. Joint pain and stiffness reported anecdotally. Fatigue or flu-like symptoms at higher doses. Long-term human safety data does not exist.
Contraindications
- Active cancer or history of any malignancy (MGF promotes cell proliferation)
- Pregnancy or breastfeeding
- Known hypersensitivity to IGF-1 or related peptides
- Uncontrolled diabetes or hypoglycemia-prone individuals
- Children and adolescents (open growth plates)
- Active infections at the intended injection site
Drug Interactions
- Insulin and sulfonylureas — increased hypoglycemia risk from additive glucose-lowering effects
- Glucocorticoids (prednisone, dexamethasone) — may inhibit the growth-promoting effect of MGF
- Other IGF-1 pathway peptides (IGF-1 LR3, HGH) — potential for compounded mitogenic effects; avoid stacking without medical oversight
- Anticoagulants — monitor for increased bruising at injection sites
Storage & Stability
Molecular Profile
Related Peptides
References
- Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration (Endocrinology 2010)PubMed 20130113
- MGF E peptide activates human muscle progenitor cells and induces an increase in their fusion potential at different ages (Mech Ageing Dev 2011)PubMed 21354439
- MGF promotes proliferation and inhibits differentiation of porcine satellite cells by down-regulation of key myogenic transcriptional factors (Mol Cell Endocrinol 2012)PubMed 22875667
- IGF-1 Ec/Mechano Growth Factor — A splice variant of IGF-1 within the growth plate (PLoS ONE 2013)PubMed 24146828
- Mechano growth factor, a splice variant of IGF-1, promotes neurogenesis in the aging mouse brain (Mol Brain 2017)PubMed 28683812